When to Order a Z-Pack (Azithromycin)
Order azithromycin (Z-Pack) for confirmed or highly suspected atypical bacterial infections—specifically Mycoplasma pneumoniae, Chlamydophila pneumoniae, or Chlamydia trachomatis—and for pertussis treatment or prophylaxis. Do not use it empirically for viral upper respiratory infections, uncomplicated bronchitis without atypical pathogen suspicion, or as a first-line agent for typical bacterial pneumonia.
Specific Clinical Indications
Community-Acquired Pneumonia with Atypical Pathogens
For Mycoplasma pneumoniae pneumonia in children: Azithromycin is the preferred oral agent at 10 mg/kg on day 1, followed by 5 mg/kg/day once daily on days 2–5 1.
For Chlamydophila pneumoniae or Chlamydia trachomatis pneumonia in children: Use the same dosing regimen as for Mycoplasma (10 mg/kg day 1, then 5 mg/kg/day for days 2–5) 1.
For adults with community-acquired pneumonia: Azithromycin 500 mg on day 1, followed by 250 mg per day on days 2–5 is appropriate when atypical pathogens are suspected 1.
Important caveat: For hospitalized patients with pneumonia, azithromycin should typically be combined with a β-lactam (not used as monotherapy) unless the patient has no cardiopulmonary disease or risk factors for drug-resistant Streptococcus pneumoniae 1.
Pertussis (Whooping Cough)
For infants <6 months: Azithromycin 10 mg/kg per day for 5 days is the preferred macrolide due to lower risk of infantile hypertrophic pyloric stenosis (IHPS) compared to erythromycin 1.
For infants and children ≥6 months: Azithromycin 10 mg/kg (maximum 500 mg) on day 1, followed by 5 mg/kg per day (maximum 250 mg) on days 2–5 1.
For adults: Azithromycin 500 mg on day 1, followed by 250 mg per day on days 2–5 1.
Critical point: Azithromycin is preferred over erythromycin in infants <1 month because erythromycin carries significant IHPS risk 1.
Chlamydial Genital Infections
For uncomplicated Chlamydia trachomatis urethritis/cervicitis in adults: Azithromycin 1 g orally as a single dose is a recommended first-line regimen, equally efficacious to doxycycline 100 mg twice daily for 7 days 1.
Advantage of azithromycin: Single-dose directly observed therapy improves compliance in populations with erratic follow-up 1.
For pregnant women: Azithromycin is FDA Pregnancy Category B and is appropriate for chlamydial infection during pregnancy 1.
Chlamydial or Gonococcal Conjunctivitis
For chlamydial conjunctivitis in children ≥8 years: Azithromycin 1 g orally as a single dose 1.
For neonatal chlamydial conjunctivitis: Azithromycin suspension 20 mg/kg/day orally once daily for 3 days (alternative to erythromycin, which has IHPS risk) 1.
When NOT to Order Azithromycin
Avoid in These Common Scenarios
Viral upper respiratory infections: Azithromycin has no role in treating the common cold, viral pharyngitis, or uncomplicated acute bronchitis without evidence of bacterial superinfection 1.
Streptococcal pharyngitis: Azithromycin is not first-line; penicillin or amoxicillin remains preferred for Streptococcus pyogenes pharyngitis.
Typical bacterial pneumonia as monotherapy in hospitalized patients: For pneumococcal pneumonia requiring hospitalization, azithromycin should be combined with a β-lactam, not used alone 1.
Acute exacerbations of chronic bronchitis without clear bacterial indication: While some studies show efficacy, the evidence is mixed, and antibiotic stewardship principles favor limiting use to minimize resistance 1.
Antibiotic Stewardship Considerations
Minimize antibiotic exposure: Use the shortest effective duration to reduce selection pressure for resistance 1.
Limit spectrum appropriately: Azithromycin should target identified or highly suspected atypical pathogens, not be used broadly for undifferentiated respiratory symptoms 1.
Resistance concerns: Widespread azithromycin use can drive macrolide resistance, particularly in Streptococcus pneumoniae and staphylococci 1.
Proper dosing is critical: Achieving adequate tissue concentrations at the infection site reduces resistance development 1.
Practical Dosing Summary
Pediatric Dosing
- Standard 5-day course: 10 mg/kg (max 500 mg) day 1, then 5 mg/kg/day (max 250 mg) days 2–5 1.
- Pertussis in infants <6 months: 10 mg/kg/day for 5 days 1.
Adult Dosing
- Standard 5-day course: 500 mg day 1, then 250 mg daily days 2–5 1.
- Single-dose for chlamydia: 1 g orally once 1.
- Extended-release formulation (Zmax): Single 2 g dose for acute bacterial sinusitis or community-acquired pneumonia (mild to moderate) 2.
Key Safety Points
Gastrointestinal side effects: Abdominal discomfort, diarrhea, nausea are common but generally mild 1.
Drug interactions: Caution with aluminum/magnesium antacids (reduce absorption), and monitor patients on digoxin, triazolam, or ergot alkaloids 1.
Hepatic impairment: Use with caution in patients with liver dysfunction 1.
IHPS risk in neonates: While lower than erythromycin, azithromycin-treated infants <1 month should still be monitored for pyloric stenosis symptoms 1.
Common Pitfalls to Avoid
Do not prescribe azithromycin reflexively for "bronchitis" without evidence of atypical bacterial infection—most cases are viral 1.
Do not use azithromycin alone for severe pneumonia requiring ICU admission; combine with a β-lactam 1.
Do not assume azithromycin covers all respiratory pathogens—it has limited activity against Haemophilus influenzae (MIC range 0.12–4 mg/L) and variable activity against Streptococcus pneumoniae depending on local resistance patterns 3.
Avoid empiric use in settings with high macrolide resistance among pneumococci without combination therapy 1.